Your browser doesn't support javascript.
loading
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
Walewski, Jan; Hellmann, Andrzej; Siritanaratkul, Noppadol; Ozsan, Guner Hayri; Ozcan, Muhit; Chuncharunee, Suporn; Goh, Ai Sim; Jurczak, Wojciech; Koren, Jan; Paszkiewicz-Kozik, Ewa; Wang, Bingxia; Singh, Shalini; Huebner, Dirk; Engert, Andreas; von Tresckow, Bastian.
Affiliation
  • Walewski J; Department of Lymphoid Malignancy, Maria Sklodowska-Curie Institute - Oncology Centre, Warszawa, Poland.
  • Hellmann A; Department of Haematology, Medical University of Gdansk, Gdansk, Poland.
  • Siritanaratkul N; Department of Medicine, Siriraj Hospital, Bangkok, Thailand.
  • Ozsan GH; Department of Haematology, Dokuz Eylul University, Izmir, Turkey.
  • Ozcan M; Department of Haematology, Ankara University School of Medicine, Ankara, Turkey.
  • Chuncharunee S; Oncology Centre, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Goh AS; Department of Medicine, Hospital Pulau Pinang, Pulau Pinang, Malaysia.
  • Jurczak W; Department of Haematology, Jagiellonian University, Kraków, Poland.
  • Koren J; Department of Haematology, Charles University, Prague, Czech Republic.
  • Paszkiewicz-Kozik E; Department of Lymphoid Malignancy, Maria Sklodowska-Curie Institute - Oncology Centre, Warszawa, Poland.
  • Wang B; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Singh S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Huebner D; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Engert A; Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • von Tresckow B; Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
Br J Haematol ; 183(3): 400-410, 2018 11.
Article in En | MEDLINE | ID: mdl-30168134
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Immunoconjugates Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: Poland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Immunoconjugates Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: Poland